Cost-utility of real-time continuous glucose monitoring versus self-monitoring of blood glucose in people with insulin-treated Type II diabetes in France

Aim: Clinical trials and real-world data for Type II diabetes both show that glycated hemoglobin (HbA1c) levels and hypoglycemia occurrence can be reduced by real-time continuous glucose monitoring (rt-CGM) versus self-monitoring of blood glucose (SMBG). The present cost-utility study investigated t...

詳細記述

書誌詳細
主要な著者: Hamza Alshannaq, Richard F Pollock, Michael Joubert, Waqas Ahmed, Gregory J Norman, Peter M Lync, Stephane Roze
フォーマット: 論文
言語:English
出版事項: Becaris Publishing Limited 2024-01-01
シリーズ:Journal of Comparative Effectiveness Research
主題: